Follow the people · Insider
Joana Goncalves
Joana Goncalves files insider transactions with the SEC as a chief medical officer of Oruka Therapeutics (ORKA). We hold 8 disclosed purchases and sales filed since 24 October 2018, 3 of them in the last 90 days.
- Files forORKA
- Disclosed buys and sells8 in all, 3 in the last 90 days
- Last disclosure17 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 22 January 2025 — 17 August 2026Chief Medical Officer · Oruka Therapeutics (ORKA)91 Form 4 lines · source: SEC Form 4
- Filed 22 October 2018 — 5 April 2024Chief Medical Officer · Cara Therapeutics (CARA)42 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 417 August 2026Common Stock · traded 17 August 2026 · filed 17 August 2026
- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 417 August 2026Common Stock · traded 17 August 2026 · filed 17 August 2026
- ▼ sold on the open market 900 shares of Oruka TherapeuticsSEC Form 417 August 2026Common Stock · traded 17 August 2026 · filed 17 August 2026
- ▼ sold on the open market 300 shares of Oruka TherapeuticsSEC Form 417 August 2026Common Stock · traded 17 August 2026 · filed 17 August 2026
- ▼ sold on the open market 3,320 shares of Oruka TherapeuticsSEC Form 417 August 2026Common Stock · traded 17 August 2026 · filed 17 August 2026
- ▼ sold on the open market 2,480 shares of Oruka TherapeuticsSEC Form 417 August 2026Common Stock · traded 17 August 2026 · filed 17 August 2026
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 417 August 2026Employee Stock Option (right to buy) · traded 17 August 2026 · filed 17 August 2026
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 417 August 2026Employee Warrant (right to buy) · traded 17 August 2026 · filed 17 August 2026
- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 415 July 2026Common Stock · traded 15 July 2026 · filed 15 July 2026
- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 415 July 2026Common Stock · traded 15 July 2026 · filed 15 July 2026
- ▼ sold on the open market 400 shares of Oruka TherapeuticsSEC Form 415 July 2026Common Stock · traded 15 July 2026 · filed 15 July 2026
- ▼ sold on the open market 2,497 shares of Oruka TherapeuticsSEC Form 415 July 2026Common Stock · traded 15 July 2026 · filed 15 July 2026
- ▼ sold on the open market 3,803 shares of Oruka TherapeuticsSEC Form 415 July 2026Common Stock · traded 15 July 2026 · filed 15 July 2026
- ▼ sold on the open market 300 shares of Oruka TherapeuticsSEC Form 415 July 2026Common Stock · traded 15 July 2026 · filed 15 July 2026
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 415 July 2026Employee Stock Option (right to buy) · traded 15 July 2026 · filed 15 July 2026
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 415 July 2026Employee Warrant (right to buy) · traded 15 July 2026 · filed 15 July 2026
- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 415 June 2026Common Stock · traded 15 June 2026 · filed 15 June 2026
- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 415 June 2026Common Stock · traded 15 June 2026 · filed 15 June 2026
- ▼ sold on the open market 1,636 shares of Oruka TherapeuticsSEC Form 415 June 2026Common Stock · traded 15 June 2026 · filed 15 June 2026
- ▼ sold on the open market 5,064 shares of Oruka TherapeuticsSEC Form 415 June 2026Common Stock · traded 15 June 2026 · filed 15 June 2026
- ▼ sold on the open market 300 shares of Oruka TherapeuticsSEC Form 415 June 2026Common Stock · traded 15 June 2026 · filed 15 June 2026
- ▼ sold on the open market 947 shares of Oruka TherapeuticsSEC Form 415 June 2026Common Stock · traded 15 June 2026 · filed 15 June 2026
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 415 June 2026Employee Stock Option (right to buy) · traded 15 June 2026 · filed 15 June 2026
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 415 June 2026Employee Warrant (right to buy) · traded 15 June 2026 · filed 15 June 2026
- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 415 May 2026Common Stock · traded 15 May 2026 · filed 15 May 2026
- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 415 May 2026Common Stock · traded 15 May 2026 · filed 15 May 2026
- ▼ sold on the open market 4,800 shares of Oruka TherapeuticsSEC Form 415 May 2026Common Stock · traded 15 May 2026 · filed 15 May 2026
- ▼ sold on the open market 2,100 shares of Oruka TherapeuticsSEC Form 415 May 2026Common Stock · traded 15 May 2026 · filed 15 May 2026
- ▼ sold on the open market 100 shares of Oruka TherapeuticsSEC Form 415 May 2026Common Stock · traded 15 May 2026 · filed 15 May 2026
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 415 May 2026Employee Stock Option (right to buy) · traded 15 May 2026 · filed 15 May 2026
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 415 May 2026Employee Warrant (right to buy) · traded 15 May 2026 · filed 15 May 2026
- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 415 April 2026Common Stock · traded 15 April 2026 · filed 15 April 2026
- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 415 April 2026Common Stock · traded 15 April 2026 · filed 15 April 2026
- ▼ sold on the open market 4,227 shares of Oruka TherapeuticsSEC Form 415 April 2026Common Stock · traded 15 April 2026 · filed 15 April 2026
- ▼ sold on the open market 2,273 shares of Oruka TherapeuticsSEC Form 415 April 2026Common Stock · traded 15 April 2026 · filed 15 April 2026
- ▼ sold on the open market 500 shares of Oruka TherapeuticsSEC Form 415 April 2026Common Stock · traded 15 April 2026 · filed 15 April 2026
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 415 April 2026Employee Stock Option (right to buy) · traded 15 April 2026 · filed 15 April 2026
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 415 April 2026Employee Warrant (right to buy) · traded 15 April 2026 · filed 15 April 2026
- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 2,921 shares of Oruka TherapeuticsSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 417 March 2026Employee Stock Option (right to buy) · traded 16 March 2026 · filed 17 March 2026
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 417 March 2026Employee Warrant (right to buy) · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 2,902 shares of Oruka TherapeuticsSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 1,177 shares of Oruka TherapeuticsSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 641 shares of Oruka TherapeuticsSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 417 March 2026Employee Stock Option (right to buy) · traded 16 March 2026 · filed 17 March 2026
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 417 March 2026Employee Warrant (right to buy) · traded 16 March 2026 · filed 17 March 2026
- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 2,921 shares of Oruka TherapeuticsSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 2,902 shares of Oruka TherapeuticsSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 1,177 shares of Oruka TherapeuticsSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 641 shares of Oruka TherapeuticsSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- ▼ sold on the open market 6,064 shares of Oruka TherapeuticsSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 417 February 2026Employee Stock Option (right to buy) · traded 17 February 2026 · filed 17 February 2026
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 417 February 2026Employee Warrant (right to buy) · traded 17 February 2026 · filed 17 February 2026
- ▼ sold on the open market 936 shares of Oruka TherapeuticsSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 417 February 2026Employee Stock Option (right to buy) · traded 17 February 2026 · filed 17 February 2026
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 417 February 2026Employee Warrant (right to buy) · traded 17 February 2026 · filed 17 February 2026
- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- ▼ sold on the open market 6,064 shares of Oruka TherapeuticsSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- ▼ sold on the open market 936 shares of Oruka TherapeuticsSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- was granted 32,500 shares of Oruka TherapeuticsSEC Form 423 January 2026Common Stock · traded 23 January 2026 · filed 23 January 2026
- was granted 130,000 shares of Oruka Therapeutics (a derivative holding)SEC Form 423 January 2026Employee Stock Option (right to buy) · traded 23 January 2026 · filed 23 January 2026
- was granted 130,000 shares of Oruka Therapeutics (a derivative holding)SEC Form 423 January 2026Employee Stock Option (right to buy) · traded 23 January 2026 · filed 23 January 2026
- was granted 32,500 shares of Oruka TherapeuticsSEC Form 423 January 2026Common Stock · traded 23 January 2026 · filed 23 January 2026
- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 416 January 2026Common Stock · traded 15 January 2026 · filed 16 January 2026
- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 416 January 2026Common Stock · traded 15 January 2026 · filed 16 January 2026
- ▼ sold on the open market 4,381 shares of Oruka TherapeuticsSEC Form 416 January 2026Common Stock · traded 15 January 2026 · filed 16 January 2026
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 416 January 2026Employee Stock Option (right to buy) · traded 15 January 2026 · filed 16 January 2026
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 416 January 2026Employee Warrant (right to buy) · traded 15 January 2026 · filed 16 January 2026
- ▼ sold on the open market 2,619 shares of Oruka TherapeuticsSEC Form 416 January 2026Common Stock · traded 15 January 2026 · filed 16 January 2026
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 416 January 2026Employee Stock Option (right to buy) · traded 15 January 2026 · filed 16 January 2026
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 416 January 2026Employee Warrant (right to buy) · traded 15 January 2026 · filed 16 January 2026
- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 416 January 2026Common Stock · traded 15 January 2026 · filed 16 January 2026
- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 416 January 2026Common Stock · traded 15 January 2026 · filed 16 January 2026
- ▼ sold on the open market 4,381 shares of Oruka TherapeuticsSEC Form 416 January 2026Common Stock · traded 15 January 2026 · filed 16 January 2026
- ▼ sold on the open market 2,619 shares of Oruka TherapeuticsSEC Form 416 January 2026Common Stock · traded 15 January 2026 · filed 16 January 2026
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 419 December 2025Employee Stock Option (right to buy) · traded 19 December 2025 · filed 19 December 2025
- exercised options over 3,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 419 December 2025Employee Warrant (right to buy) · traded 19 December 2025 · filed 19 December 2025
- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 419 December 2025Common Stock · traded 19 December 2025 · filed 19 December 2025
- exercised options over 3,500 shares of Oruka TherapeuticsSEC Form 419 December 2025Common Stock · traded 19 December 2025 · filed 19 December 2025
- ▼ sold on the open market 641 shares of Oruka TherapeuticsSEC Form 419 December 2025Common Stock · traded 19 December 2025 · filed 19 December 2025
- ▼ sold on the open market 1,787 shares of Oruka TherapeuticsSEC Form 419 December 2025Common Stock · traded 19 December 2025 · filed 19 December 2025
- ▼ sold on the open market 1,492 shares of Oruka TherapeuticsSEC Form 419 December 2025Common Stock · traded 19 December 2025 · filed 19 December 2025
- ▼ sold on the open market 3,080 shares of Oruka TherapeuticsSEC Form 419 December 2025Common Stock · traded 19 December 2025 · filed 19 December 2025
- was granted 162,500 shares of Oruka Therapeutics (a derivative holding)SEC Form 424 January 2025Employee Stock Option (right to buy) · traded 22 January 2025 · filed 24 January 2025
- ▼ sold on the open market 2,753 shares of Cara TherapeuticsSEC Form 49 April 2024Common Stock · traded 5 April 2024 · filed 9 April 2024
- ▼ sold on the open market 3,293 shares of Cara TherapeuticsSEC Form 44 March 2024Common Stock · traded 29 February 2024 · filed 4 March 2024
- ▼ sold on the open market 7,770 shares of Cara TherapeuticsSEC Form 412 February 2024Common Stock · traded 8 February 2023 · filed 12 February 2024
- was granted 13,500 shares of Cara TherapeuticsSEC Form 45 February 2024Common Stock · traded 1 February 2024 · filed 5 February 2024
- ▼ sold on the open market 2,723 shares of Cara TherapeuticsSEC Form 427 June 2023Common Stock · traded 23 June 2023 · filed 27 June 2023
- ▼ sold on the open market 2,481 shares of Cara TherapeuticsSEC Form 46 April 2023Common Stock · traded 4 April 2023 · filed 6 April 2023
- ▼ sold on the open market 6,221 shares of Cara TherapeuticsSEC Form 47 March 2023Common Stock · traded 3 March 2023 · filed 7 March 2023
- was granted 81,000 shares of Cara Therapeutics (a derivative holding)SEC Form 43 March 2023Stock Option (Right to Buy) · traded 1 March 2023 · filed 3 March 2023
- ▼ sold on the open market 2,265 shares of Cara TherapeuticsSEC Form 417 February 2023Common Stock · traded 16 February 2023 · filed 17 February 2023
- ▼ sold on the open market 2,265 shares of Cara TherapeuticsSEC Form 419 January 2023Common Stock · traded 17 January 2023 · filed 19 January 2023
- ▼ sold on the open market 2,265 shares of Cara TherapeuticsSEC Form 43 January 2023Common Stock · traded 29 December 2022 · filed 3 January 2023
- ▼ sold on the open market 2,992 shares of Cara TherapeuticsSEC Form 423 December 2022Common Stock · traded 21 December 2022 · filed 23 December 2022
- ▼ sold on the open market 1,642 shares of Cara TherapeuticsSEC Form 45 April 2022Common Stock · traded 1 April 2022 · filed 5 April 2022
- was granted 80,000 shares of Cara Therapeutics (a derivative holding)SEC Form 41 March 2022Employee Stock Option (Right to Buy) · traded 25 February 2022 · filed 1 March 2022
- was granted 20,000 shares of Cara TherapeuticsSEC Form 41 March 2022Common Stock · traded 25 February 2022 · filed 1 March 2022
- ▼ sold on the open market 1,972 shares of Cara TherapeuticsSEC Form 41 March 2022Common Stock · traded 25 February 2022 · filed 1 March 2022
- was granted 12,607 shares of Cara TherapeuticsSEC Form 421 December 2021Common Stock · traded 17 December 2021 · filed 21 December 2021
- ▼ sold on the open market 1,000 shares of Cara TherapeuticsSEC Form 43 November 2021Common Stock · traded 1 November 2021 · filed 3 November 2021
- ▼ sold on the open market 1,000 shares of Cara TherapeuticsSEC Form 428 October 2021Common Stock · traded 27 October 2021 · filed 28 October 2021
- ▼ sold on the open market 2,110 shares of Cara TherapeuticsSEC Form 41 September 2021Common Stock · traded 30 August 2021 · filed 1 September 2021
- was granted 6,400 shares of Cara TherapeuticsSEC Form 426 August 2021Common Stock · traded 24 August 2021 · filed 26 August 2021
- ▼ sold on the open market 3,000 shares of Cara TherapeuticsSEC Form 423 April 2021Common Stock · traded 21 April 2021 · filed 23 April 2021
- was granted 16,000 shares of Cara TherapeuticsSEC Form 41 April 2021Common Stock · traded 30 March 2021 · filed 1 April 2021
- was granted 32,000 shares of Cara Therapeutics (a derivative holding)SEC Form 41 April 2021Employee Stock Option (Right to Buy) · traded 30 March 2021 · filed 1 April 2021
- ▼ sold on the open market 3,000 shares of Cara TherapeuticsSEC Form 424 March 2021Common Stock · traded 22 March 2021 · filed 24 March 2021
- was granted 10,000 shares of Cara TherapeuticsSEC Form 48 March 2021Common Stock · traded 4 March 2021 · filed 8 March 2021
- ▼ sold on the open market 3,093 shares of Cara TherapeuticsSEC Form 48 March 2021Common Stock · traded 5 March 2021 · filed 8 March 2021
- was granted 4,000 shares of Cara TherapeuticsSEC Form 425 February 2021Common Stock · traded 23 February 2021 · filed 25 February 2021
- ▼ sold on the open market 3,372 shares of Cara TherapeuticsSEC Form 425 February 2021Common Stock · traded 25 February 2021 · filed 25 February 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.